Roflumilast is safe and effective in improving symptoms and lung function in severe COPD

Roflumilast is safe and effective in improving symptoms and lung function in severe COPD

The case of a 66-year-old man with severe chronic obstructive pulmonary disease (COPD) is presented. Diagnosis was based on baseline pulmonary function tests (PFTs) and clinical examination. Therapy with tiotropium 18 μg (once daily) and salmeterol/fluticasone 50/500 μg (twice daily) failed to achie...

Full description

Bibliographic Details
Main Authors: Matteo Bonini, Paolo Palange
Format: Article
Language:English
Published: PAGEPress Publications 2015-08-01
Series:Monaldi Archives for Chest Disease
Subjects:
Roflumilast
COPD
Case report
Lung function
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/28

Similar Items

Similar Items